• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:张宇.药品监管政务新媒体的权威性与传播力平衡策略研究——以“中国药闻”为例[J].药学研究,2026,45(9):1013-1017,1071[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 230次   下载 196次 本文二维码信息
码上扫一扫!
药品监管政务新媒体的权威性与传播力平衡策略研究——以“中国药闻”为例
张宇
字体:加大+|默认|缩小-
(国家药品监督管理局新闻宣传中心,北京 100037)
摘要:
新时代以来,我国药品监管政务新媒体建设在取得一定成果的同时,也面临着权威性与传播力难以兼容的二元困境,从根本上限制了药品监管政务新媒体的长远发展。针对这一问题,以“中国药闻”为典型的药品监管政务新媒体品牌,通过构建“平台差异化布局、系统层级化联动、分众化传播”的三维传播体系,达成了行政与社会资源的有效整合、权威信息的广泛传播以及科普知识的精准触达,探寻出一条解决上述困境的实践路径,为提升药品监管传播效能提供了经验参考。
关键词:  药品监管  政务新媒体  中国药闻  传播矩阵
DOI:10.13506/j.cnki.jpr.2026.09.008
基金项目:
收稿日期:2026-05-29   修回日期:2026-07-20   出版日期:2026-09-30
Research on strategies for balancing authority and communication reach in government new media for drug regulation: A case study of "Chinese Pharmaceutical News"
ZHANG Yu
(News and Publicity Center,National Medical Products Administration,Beijing 100037,China)
Abstract:
Ever since the new era started, China has made significant progress in the development of government new media for drug regulation. These platforms continue to face a structural dilemma in which authority and communication reach are often difficult to reconcile. This kind of tension fundamentally limits the sustainable growth of government new media in the drug regulation area. In response to this challenge, government new media brands for drug regulation, represented by "Chinese Pharmaceutical News", have developed a three-dimensional communication system featuring differentiated platform deployment, hierarchical system-wide coordination, and audience-oriented integrated communication. This system has effectively integrated administrative and social resources, expanded the dissemination of authoritative information, and enabled the precise delivery of science popularization content. It offers a practical pathway for resolving the tension between authority and communication reach and provides useful experience for improving the effectiveness of pharmaceutical regulatory communication.
Key words:  Drug regulation  Government new media  Chinese Pharmaceutical News  Communication matrix
今日访问量:2274    总访问量:55338616
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司